Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Human alpha-1-glycoprotein and its interactions with drugs.

Israili ZH, Dayton PG.

Drug Metab Rev. 2001 May;33(2):161-235. Review.

PMID:
11495502
2.

Enhancement of xenobiotic elimination: role of intestinal excretion.

Israili ZH, Dayton PG.

Drug Metab Rev. 1984;15(5-6):1123-59. Review. No abstract available.

PMID:
6396054
3.

The binding of ketamine to plasma proteins: emphasis on human plasma.

Dayton PG, Stiller RL, Cook DR, Perel JM.

Eur J Clin Pharmacol. 1983;24(6):825-31. No abstract available.

PMID:
6884418
4.

Elimination of drugs by passive diffusion from blood to intestinal lumen: factors influencing nonbiliary excretion by the intestinal tract.

Dayton PG, Israili ZH, Henderson JD.

Drug Metab Rev. 1983;14(6):1193-206. Review. No abstract available.

PMID:
6373210
5.

Dose-dependent pharmacokinetics: emphasis on phase I metabolism.

Dayton PG, Sanders JE.

Drug Metab Rev. 1983;14(3):347-405. Review. No abstract available.

PMID:
6347591
6.

Gas chromatographic analysis of ketamine and norketamine in plasma and urine: nitrogen-sensitive detection.

Stiller RL, Dayton PG, Perel JM, Hug CC Jr.

J Chromatogr. 1982 Nov 12;232(2):305-14.

PMID:
6818238
7.

Hydralazine reactions.

Dayton PG, Israili ZH.

Science. 1981 Oct 2;214(4516):94-5. No abstract available.

PMID:
7280686
8.

A nonmetabolized analogue of phenytoin.

Henderson JD, Dayton PG, Israili ZH, Mandell L.

J Med Chem. 1981 Jul;24(7):843-7.

PMID:
7277391
9.

Is a photo-oxidation product of histidine one of the triggers of induction of cytochrome P-450 drug-metabolizing enzyme systems?

Dayton PG, Israili ZH.

Drug Metab Dispos. 1981 Jul-Aug;9(4):391. No abstract available.

PMID:
6114841
10.

Plasma concentrations of isoniazid in children with tuberculous infections.

Olson WA, Pruitt AW, Dayton PG.

Pediatrics. 1981 Jun;67(6):876-8.

PMID:
7232051
11.

Clinical pharmacokinetics of probenecid.

Cunningham RF, Israili ZH, Dayton PG.

Clin Pharmacokinet. 1981 Mar-Apr;6(2):135-51. Review.

PMID:
7011657
12.

Aldehyde conjugates.

Dayton PG.

Drug Metab Dispos. 1980 Mar-Apr;8(2):120. No abstract available.

PMID:
6103785
13.

New spectrophotofluorometric assay for probenecid.

Cunningham RF, Israili ZH, Dayton PG.

J Pharm Sci. 1978 Mar;67(3):434-6.

PMID:
641745
14.

The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man.

Yü TF, Perel J, Berger L, Roboz J, Israili ZH, Dayton PG.

Am J Med. 1977 Nov;63(5):723-8.

PMID:
930947
15.

Coumarin resistance: a diagnostic and therapeutic approach.

Arnold RS, Israili ZH, Dayton PG, Wenger NK.

South Med J. 1977 Oct;70(10):1191-2.

PMID:
910171
16.

Probenecid in CSF and plasma of rabbits and dogs measured by radioimmunoassay.

Shei WL, Mu JY, Cunningham RF, Israili ZH, Dayton PG.

Psychopharmacology (Berl). 1977 Aug 16;53(3):315-8.

PMID:
408862
17.

Novel routes of drug metabolism. A survey.

Israili ZH, Dayton PG, Kiechel JR.

Drug Metab Dispos. 1977 Jul-Aug;5(4):411-5. Review. No abstract available.

PMID:
19221
18.

Variations in the fate of triameterene.

Pruitt AW, Winkel JS, Dayton PG.

Clin Pharmacol Ther. 1977 May;21(5):610-9.

PMID:
870273
19.

Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.

Cunningham RF, Perel JM, Israili ZH, Dayton PG.

Drug Metab Dispos. 1977 Mar-Apr;5(2):205-10.

PMID:
15815
20.

Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.

Faraj BA, Dayton PG, Camp VM, Wilson JP, Malveaux EF, Schlant RC.

J Pharmacol Exp Ther. 1977 Feb;200(2):384-93.

PMID:
839443
21.

Spectrophotofluorometric assay for isoniazid and acetyl isoniazid in plasma adapted to pediatric studies.

Olson WA, Dayton PG, Israili ZH, Pruitt AW.

Clin Chem. 1977;23(4):745-8.

PMID:
844172
22.

Metabolism of hydralazine.

Israili ZH, Dayton PG.

Drug Metab Rev. 1977;6(2):283-305. Review. No abstract available.

PMID:
344023
23.

Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.

Rose HJ, Pruitt AW, Dayton PG, McNay JL.

J Pharmacol Exp Ther. 1976 Dec;199(3):490-7.

PMID:
994014
24.

(14C)Methylphenidate hydrochloride. Studies on disposition in rat brain.

Segal JL, Cunningham RF, Dayton PG, Israili ZH.

Drug Metab Dispos. 1976 Mar-Apr;4(2):140-6.

PMID:
5258
25.

Duration of hydralazine action in hypertension.

O'Malley K, Segal JL, Israili ZH, Boles M, McNay JL, Dayton PG.

Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):581-6.

PMID:
1102235
26.

Determination of plasma and tissue levels of tyramine by radioimmunoassay.

Faraj BA, Mu JY, Lewis MS, Wilson JP, Israili ZH, Dayton PG.

Proc Soc Exp Biol Med. 1975 Jul;149(3):664-9.

PMID:
1170571
27.

Metabolism of tolmetin in rat, monkey, and man.

Sumner DD, Dayton PG, Cucinell SA, Plostnieks J.

Drug Metab Dispos. 1975 Jul-Aug;3(4):283-6.

PMID:
240658
28.

A complex pattern of disposition of phenytoin in severe intoxication.

Pruitt AW, Zwiren GT, Patterson JH, Dayton PG, Cook CE, Wall ME.

Clin Pharmacol Ther. 1975 Jul;18(1):112-20.

PMID:
238781
29.

Metabolism and disposition of diazoxide. A mini-review.

Dayton PG, Pruitt AW, Faraj BA, Israili ZH.

Drug Metab Dispos. 1975 May-Jun;3(3):226-9. No abstract available.

PMID:
238822
31.

Transfer characteristics of triamterene and its analogs. Central nervous system, placenta, and kidney.

Pruitt AW, McNay JL, Dayton PG.

Drug Metab Dispos. 1975 Jan-Feb;3(1):30-41.

PMID:
234832
32.

Metabolism and disposition of methylphenidate-14C: studies in man and animals.

Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA, Dayton PG.

J Pharmacol Exp Ther. 1974 Dec;191(3):535-47. No abstract available.

PMID:
4473537
33.

Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method.

Kinkade JM Jr, Vogler WR, Dayton PG.

Biochem Med. 1974 Aug;10(4):337-50. No abstract available.

PMID:
4853669
34.

Metabolism and disposition of hydralazine-14C in man and dog.

Lesser JM, Israili ZH, Davis DC, Dayton PG.

Drug Metab Dispos. 1974 Jul-Aug;2(4):351-60. No abstract available.

PMID:
4153405
35.

Studies of the specificity of an antibody directed against probenecid. Investigations with probenecid analogs.

Mu JY, Faraj BA, Israili ZH, Dayton PG.

Life Sci. 1974 Mar 1;14(5):837-52. No abstract available.

PMID:
4208149
36.

Imipramine and chlorpromazine in hepatic microsomal systems.

Perel JM, O'Brien L, Black NB, Bellward GD, Dayton PG.

Adv Biochem Psychopharmacol. 1974;9(0):201-12. No abstract available.

PMID:
4836204
37.

Metabolism of diazoxide in man and experimental animals.

Pruitt AW, Faraj BA, Dayton PG.

J Pharmacol Exp Ther. 1974 Jan;188(1):248-56. No abstract available.

PMID:
4203373
38.

Influence of binding on drug metabolism and distribution.

Dayton PG, Israili ZH, Perel JM.

Ann N Y Acad Sci. 1973 Nov 26;226:172-94. Review. No abstract available.

PMID:
4588440
39.

Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation.

Dayton PG, Perel JM, Cunningham RF, Israili ZH, Weiner IM.

Drug Metab Dispos. 1973 Nov-Dec;1(6):742-51. No abstract available.

PMID:
4156295
40.

Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites.

Israili ZH, Cucinell SA, Vaught J, Davis E, Lesser JM, Dayton PG.

J Pharmacol Exp Ther. 1973 Oct;187(1):138-51. No abstract available.

PMID:
4583459
41.

Coumarin resistance in a Negro woman.

Zager J, Tjandramaga TB, Cucinell SA, Dayton PG.

Ann Intern Med. 1973 May;78(5):775-6. No abstract available.

PMID:
4123117
42.

Disposition of diazoxide in children.

Pruitt AW, Dayton PG, Patterson JH.

Clin Pharmacol Ther. 1973 Jan-Feb;14(1):73-82. No abstract available.

PMID:
4683074
43.

Thiopental and the fetal liver.

Finster M, Morishima HO, Mark LC, Perel JM, Dayton PG, James LS.

Anesthesiology. 1972 Nov;37(5):571-2. No abstract available.

PMID:
4673019
44.

, '- and , '-deuterium-labeled dopamine. Synthesis and pharmacologic actions.

Perel JM, Dawson DK, Dayton PG, Goldberg LI.

J Med Chem. 1972 Jul;15(7):714-6. No abstract available.

PMID:
5043869
45.

Metabolites of probenecid. Chemical, physical, and pharmacological studies.

Israili ZH, Percel JM, Cunningham RF, Dayton PG, Yü TF, Gutman AB, Long KR, Long RC Jr, Goldstein JH.

J Med Chem. 1972 Jul;15(7):709-13. No abstract available.

PMID:
5043868
46.

Studies with triamterene, a substituted pteridine. Unusual brain to plasma ratio in mammals.

Dayton PG, Pruitt AW, McNay JL, Steinhorst J.

Neuropharmacology. 1972 May;11(3):435-46. No abstract available.

PMID:
5050448
47.

Microsomal N-oxidation of dapson as a cause of methemoglobin formation in human red cells.

Cucinell SA, Israili ZH, Dayton PG.

Am J Trop Med Hyg. 1972 May;21(3):322-31. No abstract available.

PMID:
4554497
48.

Tissue thiopental concentrations in the fetus and newborn.

Finster M, Morishima HO, Mark LC, Perel JM, Dayton PG, James LS.

Anesthesiology. 1972 Feb;36(2):155-8. No abstract available.

PMID:
5062056
49.

Observations on the disposition of probenecid in patients receiving allopurinol.

Tjandramaga TB, Cucinell SA, Israili ZH, Perel JM, Dayton PG, Yü TF, Gutman AB.

Pharmacology. 1972;8(4):259-72. No abstract available.

PMID:
4572009
50.

A comparison of the binding of drugs to adult and cord plasma.

Pruitt AW, Dayton PG.

Eur J Clin Pharmacol. 1971 Dec;4(1):59-62. No abstract available.

PMID:
5151394

Supplemental Content

Loading ...
Support Center